Evidence-based Cardiology

List of contributors, viii Preface to the third edition, xiv Classification of recommendations and levels of evidence, xvi List of abbreviations, xvii Part I: General concepts and critical appraisal Salim Yusuf, Editor 1 Evidence-based decision making: patient physician interface, 3 Philip J Devereaux, Marc Pfeffer, Salim Yusuf 2 Obtaining incremental information from diagnostic tests, 14 Raymond J Gibbons 3 Clinical trials and meta-analysis, 26 Jonathan R Emberson, Colin Baigent 4 Understanding concepts related to health economics, 38 Mark A Hlatky 5 Major vascular complications in patients undergoing non-cardiac surgery: magnitude of the problem, risk prediction, surveillance, and prevention, 47 Philip J Devereaux, Matthew Chan, John Eikelboom 6 Implementing evidence-based medicine in cardiology, 63 Brahmajee K Nallamothu, Thomas T Tsai, Jack V Tu 7 The application of evidence-based medicine to employment fitness standards: the transportation industries with special reference to aviation, 79 Michael Joy Part II: Prevention of cardiovascular diseases Salim Yusuf and John A Cairns, Editors 8 Global perspective on cardiovascular disease, 95 K Srinath Reddy 9 Avoidance of worldwide vascular deaths and total deaths from smoking, 111 Prabhat Jha, Prem Mony, James Moore, Witold Zatonski 10 Tobacco and cardiovascular disease: achieving smoking cessation in cardiac patients, 125 Andrew Pipe 11 Lipids and cardiovascular disease, 138 Malcolm Law 12 Use of lipid-lowering agents in the prevention of cardiovascular disease, 147 R Alan Failor, Jeffrey L Probstfi eld 13 Blood pressure and cardiovascular disease, 165 Curt D Furberg, Bruce M Psaty, Elsayed Z Soliman 14 Dysglycemia and the risk of cardiovascular events, 179 Hertzel C Gerstein, Zubin Punthakee 15 Physical activity and exercise in cardiovascular disease prevention and rehabilitation, 190 Ray W Squires 16 Psychosocial factors, 201 Annika Rosengren 17 The social determinants of cardiovascular disease, 211 Martin McKee, Clara K Chow 18 Obesity, 221 Raj S Padwal, Arya M Sharma 19 Ethnicity and cardiovascular disease, 235 Clara K Chow, Sonia S Anand, Salim Yusuf 20 Fetal origins of coronary artery disease, 258 Katherine M Morrison, Stephanie Atkinson, Koon K Teo 21 Genetics of coronary heart disease, 268 Michael S Cunnington, Bernard D Keavney 22 Molecular genetics of cardiovascular disorders, 288 Ali J Marian, Robert Roberts 23 Diet and cardiovascular disease, 304 K Srinath Reddy 24 Integrating approaches to prevention of cardiovascular disease, 328 David A Wood, Kornelia Kotseva Part IIIa: Stable coronary artery disease John A Cairns and Bernard J Gersh, Editors 25 Medical management of stable coronary artery disease, 345 William E Boden 26 Percutaneous intervention, 357 David A Wood, Rohit Khurana, Christopher E Buller 27 Surgical coronary artery revascularization, 379 Morgan L Brown, Thoralf M Sundt III 28 Comparisons of percutaneous coronary intervention and coronary artery bypass grafting, 392 Arashk Motiei, Thoralf M Sundt III, Charanjit S Rihal Part IIIb: Acute coronary syndromes John A Cairns and Bernard J Gersh, Editors 29 Non-ST segment elevation acute coronary syndromes: unstable angina and non-ST segment elevation myocardial infarction, 409 Pierre Theroux, John A Cairns 30 Early prehospital management of ST segment elevation myocardial infarction, 444 Robert C Welsh, Paul W Armstrong 31 Reperfusion therapies for ST segment elevation myocardial infarction, 456 Joseph B Muhlestein, Jeffrey L Anderson 32 Antithrombotic therapies for patients with ST segment elevation myocardial infarction, 475 Andrew J Lucking, Keith A A Fox 33 Complications after myocardial infarction, 495 Peter L Thompson 34 An integrated approach to the management of patients after the early phase of ST segment elevation myocardial infarction, 516 Pedro L Sanchez, Francisco Fernandez- Aviles Part IIIc: Arrhythmias A John Camm and John A Cairns, Editors 35 Atrial fibrillation: rhythm and rate control therapies, 531 Irina Savelieva, Albert L Waldo, A John Camm 36 Atrial fi brillation: upstream therapies, 568 Antonios Kourliouros, Irina Savelieva, Marjan Jahangiri, A John Camm 37 Atrial fibrillation: antithrombotic therapy, 581 John A Cairns, Stuart Connolly 38 Ablation therapy for atrial fi brillation, 596 Conor D Barrett, Chi Keong Ching, Luigi Di Biase, Claude S Elayi, David J Burkhardt, Rodney Horton, Andrea Natale 39 Supraventricular tachycardia, 606 Erica D Penny-Peterson, Gerald V Naccarelli 40 Prevention and treatment of life-threatening ventricular arrhythmia and sudden death, 619 Carlos A Morillo, Adrian Baranchuk 41 Pacemaker therapy, including cardiac resynchronization therapy, 636 William D Toff, A John Camm 42 Syncope, 673 David G Benditt, Fei Lu, Scott Sakaguchi 43 Cardiopulmonary resuscitation, 692 Michael Colquhoun 44 Arrhythmias due to monogenic disorders, 706 Dawood Darbar, Prince Kannankeril, Dan M L Roden 45 Arrhythmiagenic right ventricular cardiomyopathy, 721 Deirdre Ward, Perry M Elliott Part IIId: Specifi c cardiovascular disorders: left ventricular dysfunction Salim Yusuf, Editor 46 Epidemiology and prevention of heart failure and management of asymptomatic left ventricular systolic dysfunction, 735 J Paul Rocchiccioli, John J V McMurray 47 Management of overt heart failure, 756 Paul J Hauptman, Karl Swedberg 48 Acute myocarditis and dilated cardiomyopathy, 784 Leslie T Cooper Jr, Oyere K Onuma 49 Management of hypertrophic cardiomyopathy, 796 Barry J Maron 50 Infective and infi ltrative cardiomyopathies, 808 Stavros Kounas, Perry M Elliott 51 Chagas heart disease, 823 J Antonio Marin-Neto, Anis Rassi Jr, Benedito Carlos Maciel, Marcus Vinicius Simoes, Andre Schmidt Part IIIe: Specifi c cardiovascular disorders: pericardial disease Bernard J Gersh, Editor 52 Pericardial disease: an evidence-based approach to clinical management, 845 Faisal F Syed, Bongani M Mayosi Part IIIf: Specifi c cardiovascular disorders: valvular heart disease Bernard J Gersh, Editor 53 Rheumatic heart disease: prevention and acute treatment, 861 Bongani M Mayosi, Patrick J Commerford 54 Mitral valve disease: indications for surgery, 869 Blase A Carabello 55 Surgical indications in aortic valve disease, 878 Sunil Mankad, Heidi M Connolly, Shahbudin H Rahimtoola 56 Non-surgical aortic valve therapy: balloon valvuloplasty and transcatheter aortic valve replacement, 896 Robert H Boone, John G Webb 57 Balloon valvuloplasty: mitral valve, 913 Zoltan G Turi 58 Valve repair and choice of valve, 927 Shafie S Fazel, Tirone E David 59 Infective endocarditis, 941 Zainab Samad, Andrew Wang 60 Antithrombotic therapy after heart valve replacement, 957 Jack C J Sun, John W Eikelboom Part IIIg: Specifi c cardiovascular disorders: other conditions Bernard J Gersh and Salim Yusuf, Editors 61 Stroke, 971 Brian H Buck, Ashfaq Shuaib, Craig Anderson 62 Heart disease and pregnancy, 993 Rachel M Wald, Samuel C Siu 63 Adult congenital heart disease, 1006 Elisabeth Bedard, Michael A Gatzoulis 64 Venous thromboembolic disease, 1032 Lori-Ann Linkins, Clive Kearon 65 Peripheral arterial disease, 1050 Catherine McGorrian, Sonia S Anand 66 Cardiac risk in those undergoing non-cardiac surgery, 1068 Ameeth Vedre, Kim A Eagle 67 Clinical management of diseases of the aorta, 1079 Thoralf M Sundt III 68 Cardiac transplantation: indications and postoperative management, 1099 Barry Boilson, Sudhir Kushwaha 69 Renal dysfunction, 1110 Johannes F E Mann, Ernesto L Schiffrin 70 Pulmonary hypertension, 1118 Brendan P Madden Part IV: Clinical applications Ernest L Fallen, Editor 71 Clinical applications of external evidence, 1135 Ernest L Fallen, Salim Yusuf 72 Stable angina: choice of PCI versus CABG versus drugs, 1138 William S Weintraub 73 Non-ST segment acute coronary syndrome, 1142 David Fitchett 74 Acute ST segment elevation myocardial infarction, 1152 Ernest L Fallen 75 Secondary prevention strategies post myocardial infarction, 1157 Jacques Genest 76 Heart failure, 1164 Michael M Givertz, Garrick C Stewart 77 Atrial fibrillation, 1170 Michael Klein 78 The case for and against implantable cardioverter defibrillators in patients with coronary artery disease, 1174 Jeffrey S Healey 79 Bradyarrhythmias choice of pacemakers, 1178 Pablo B Nery, Carlos A Morillo 80 Peripheral arterial disease with suspect coronary artery disease, 1183 Victor Aboyans, Michael H Criqui 81 Valvular heart disease: timing of surgery, 1187 Jon-David R Schwalm, Victor Chu Index, 1191 The colour plate section can be found facing p. 941